INTERNATIONAL PATENT: KEMIJSKI INSTITUT FILES APPLICATION FOR "A PHARMACEUTICAL FORMULATION THAT COMBINES HYDROXYCHLOROQUINE OR ITS ANALOGS WITH NUCLEIC ACID-BASED THERAPEUTIC INGREDIENTS TO SUPPRESS EXCESSIVE INFLAMMATION TRIGGERED BY THE INTRODUCTION OF NUCLEIC ACIDS"

GENEVA, Feb. 3 -- KEMIJSKI INSTITUT (Hajdrihova 191000 Ljubljana) filed a patent application (PCT/EP2024/071126) for "A PHARMACEUTICAL FORMULATION THAT COMBINES HYDROXYCHLOROQUINE OR ITS ANALOGS WITH NUCLEIC ACID-BASED THERAPEUTIC INGREDIENTS TO SUPPRESS EXCESSIVE INFLAMMATION TRIGGERED BY THE INTRODUCTION OF NUCLEIC ACIDS" on Jul 25, 2024. With publication no. WO/2025/021922, the details related to the patent application was published on Jan 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JERALA, Roman (Mencingerjeva ulica 791000 Ljubljana), LAINSČEK, Dusko (Stihova ulica 141000 Lj...